VYANT BIO, INC (VYNT) Financial Statements
VYANT BIO, INC (VYNT) files with the U.S. Securities and Exchange Commission under CIK 0001349929. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2022
- Revenue
- $666.00 thousand
- Net Income
- -$22.69 million
- Total Assets
- $15.21 million
- Net Cash from Operations
- -$13.68 million
Fiscal year ended Dec 31, 2022. Latest periodic SEC filing: Mar 31, 2023. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for VYNT in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History